GRI Bio to Present at the H.C. Wainwright 27th Annual Global Investment Conference

Live webcast presentation with CEO, Dr. Marc Hertz, on September 9^th at 3:00 PM ET

LA JOLLA, CA, Sept. 03, 2025 (GLOBE NEWSWIRE) -- GRI Bio, Inc. (NASDAQ: GRI) (“GRI Bio” or the “Company”), a biotechnology company advancing an innovative pipeline of Natural Killer T (“NKT”) cell modulators for the treatment of inflammatory, fibrotic and autoimmune diseases, today announced that Marc Hertz, PhD, Chief Executive Officer of GRI Bio, will present at 3:00 PM ET on Tuesday, September 9, 2025 at the H.C. Wainwright 27^th Annual Global Investment Conference being held in New York, NY. 

Read more at globenewswire.com